调强放疗联合腔内后装放疗治疗晚期宫颈癌的临床研究

所属专题：文献；

短篇论著

陈朝晖¹^,^*(

)

全文 ( ) 下载PDF ( ) 导出引用

表1 两组患者放疗疗效比较[n(%)]

Table 1 Comparison of curative effect after treatment between two groups[n(%)]

组别	n	CR	PR	DR	PD
治疗组	12	9(75.0)	2(16.7)	1(8.3)	0(0.0)
对照组	14	4(28.6)	6(42.9)	4(28.6)	0(0.0)

表1 两组患者放疗疗效比较[n(%)]

Table 1 Comparison of curative effect after treatment between two groups[n(%)]

组别	n	CR	PR	DR	PD
治疗组	12	9(75.0)	2(16.7)	1(8.3)	0(0.0)
对照组	14	4(28.6)	6(42.9)	4(28.6)	0(0.0)

表2 两组患者治疗后近期并发症发生率比较[n(%)]

Table 2 Comparison of rates of complications after treatment between two groups[n(%)]

分组	n	骨髓抑制	放射性直肠炎	放射性膀胱炎	放射性皮炎
治疗组	12	4(33.3)	4(33.3)	0 (0.0)	0 (0.0)
对照组	14	9(64.3)	8(57.1)	3(21.4)	2(14.3)

表2 两组患者治疗后近期并发症发生率比较[n(%)]

Table 2 Comparison of rates of complications after treatment between two groups[n(%)]

分组	n	骨髓抑制	放射性直肠炎	放射性膀胱炎	放射性皮炎
治疗组	12	4(33.3)	4(33.3)	0 (0.0)	0 (0.0)
对照组	14	9(64.3)	8(57.1)	3(21.4)	2(14.3)

[1]	Rose PG, Bundy BN, Waiking EB, et al.Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer[J].NEJM, 1999, 340:1144-1153.
[2]	McNeil C.New standard of care for cervical cancer sets stage for next questions[J].J Natl Cancer Inst, 1999, 91:500-501.
[3]	Sundar S, Symonds P, Deeham C.Tolerance of pelvix organs to radiation treatment for carcinoma of cervix[J]. Clin Oncol, 2003, 15:240-247.
[4]	Sun S, Zhang FQ. Intensity modulated radiotherapy for cervical cancer[J].J Oncol, 2006, 12(5):377.
[5]	Yu X, Wang G, Yang XX, et al. Dosimetric characteristic for cervical cancer patients receiving intensity modulated radiation therapy[J]. Mod Oncol, 2009, 17(12):2412.
[6]	Molia M, Escude L, Nouet P, et al.Fractionated stereotactic radiotherapy boost for Gynecologic tumors:An alternative to brachytherapy[J].Int J Radiat Oncol Biol Phys, 2005, 62:118-124.

No related articles found!

阅读次数

全文

摘要